Cangene Sees Drop in Q3 Earnings
Winnipeg Free Press (June 14, 2007)
Permanent Link:
http://ca.vlex.com/vid/cangene-sees-drop-in-64003510
Id. vLex: VLEX-64003510
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Revenues for the quarter were $22.7 million compared with $28.7 million as sales of its VIG drug fell. The VIG drug is Cangene's first biodefence product licensed in the U.S. and is used to treat adverse reactions to the smallpox vaccine.
Cangene Sees Drop in Q3 Earnings
TORONTO -- Winnipeg-based drug developer and ...
Try vLex for FREE for 3 days
Access legal information from Canada including:
- Legal Books and Journals
- Case Law
- Legislation
- News and Business
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
Other documents:
tragedy blamed on coast guard |
arbitrator rules in favour of minnedosa teacher |
Assigning the Honourable Lynne Yelich to Assist the Minister of Western Economic Diversification - Order
|
societe d assistance scientifique informatique et technique en abrege sasit societe anonyme avenue freres becque 15 1082 br... |
Decreti Decisorio nº 6600 of T.A.R - Toscana Firenze of November 21 2005
|
15 DECEMBER 1999 - Koninklijk besluit tot wijziging van het KB/WIB 92 op het stuk van de bedrijfsvoorheffing 1
|
decreti decisorio nº 1784 of t.a.r - lazio latina of december 19 2005
|
ordinanze collegiali n 406 of t.a.r - sicilia palermo of november 22 2005
|
Suivant acte dressé au greffe du tribunal de première instance de Liège, en date du 26 mars 2007 : Mme Hock, Muriel, né à Saint-Josse-ten-Noode le 30...
